The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Carter Kenneth C since 2006.
The trader's CIK number is 1332217.
At the time of the last reporting, Carter Kenneth C was the President and CEO of Avalon Pharmaceuticals Inc. (stock ticker symbol AVRX).
Also see all insider trading activities at Avalon Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2008 | AVRX | 4,832 | $12,307 | 2,032 | $5,191 | 0 | $0 |
| 2006 | AVRX | 5,000 | $15,510 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-01-17 | AVRX | Sale | 2,032 | 2.56 | 5,191 |
| 2008-01-23 | AVRX | Buy | 4,832 | 2.55 | 12,307 |
| 2006-08-30 | AVRX | Buy | 3,000 | 2.99 | 8,970 |
| 2006-08-22 | AVRX | Buy | 2,000 | 3.27 | 6,540 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Carter Kenneth C (President and CEO of Avalon Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.